OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) has received an average rating of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $30.75.
Several research analysts have issued reports on KIDS shares. Canaccord Genuity Group raised their price objective on shares of OrthoPediatrics from $28.00 to $30.00 and gave the stock a “buy” rating in a research report on Wednesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of OrthoPediatrics in a research note on Tuesday, November 3rd. Truist Financial upped their target price on shares of OrthoPediatrics from $22.00 to $28.00 and gave the company a “hold” rating in a report on Wednesday, October 28th. TD Cowen increased their target price on shares of OrthoPediatrics from $23.00 to $28.00 and gave the stock a “buy” rating in a research note on Wednesday, October 28th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $35.00 target price on shares of OrthoPediatrics in a research note on Wednesday, October 28th.
Check Out Our Latest Research Report on KIDS
Insider Buying and Selling at OrthoPediatrics
In other OrthoPediatrics news, major shareholder Squadron Capital Llc sold 302,369 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.01, for a total transaction of $6,352,772.69. Following the completion of the sale, the insider directly owned 6,201,764 shares of the company’s stock, valued at approximately $130,299,061.64. This trade represents a 4.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Jennifer N. Pritzker sold 302,369 shares of OrthoPediatrics stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $21.01, for a total value of $6,352,772.69. Following the completion of the transaction, the insider owned 6,201,764 shares in the company, valued at $130,299,061.64. This trade represents a 4.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,100,000 shares of company stock valued at $46,747,931 in the last ninety days. Insiders own 32.50% of the company’s stock.
Institutional Investors Weigh In On OrthoPediatrics
Several large investors have recently modified their holdings of KIDS. GAMMA Investing LLC grew its holdings in OrthoPediatrics by 70.3% during the third quarter. GAMMA Investing LLC now owns 1,165 shares of the company’s stock worth $26,000 after acquiring an additional 481 shares during the period. Waverly Advisors LLC raised its position in OrthoPediatrics by 6.7% in the second quarter. Waverly Advisors LLC now owns 12,366 shares of the company’s stock worth $237,000 after acquiring an additional 775 shares in the last quarter. Legal & General Group Plc purchased a new position in OrthoPediatrics in the second quarter worth $34,000. Quantinno Capital Management LP purchased a new position in OrthoPediatrics in the first quarter worth $160,000. Finally, Advisors Asset Management Inc. acquired a new stake in OrthoPediatrics in the third quarter valued at $228,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.
OrthoPediatrics Price Performance
Shares of NASDAQ KIDS opened at $32.35 on Monday. The company has a current ratio of 4.55, a quick ratio of 2.00 and a debt-to-equity ratio of 0.29. OrthoPediatrics has a twelve month low of $14.42 and a twelve month high of $34.53. The stock has a 50 day moving average of $25.07 and a two-hundred day moving average of $20.30. The stock has a market cap of $844.66 million, a P/E ratio of -22.62 and a beta of 0.90.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.02). The firm had revenue of $72.66 million during the quarter, compared to analyst estimates of $68.50 million. OrthoPediatrics had a negative net margin of 12.83% and a negative return on equity of 8.10%. On average, research analysts forecast that OrthoPediatrics will post -1.09 earnings per share for the current year.
About OrthoPediatrics
OrthoPediatrics Corp. develops and markets orthopedic implants and instruments designed specifically for children and adolescents. Its products support surgeons treating a range of pediatric conditions, including fractures, spinal deformities, limb-length differences and other orthopedic disorders. The company’s portfolio includes systems for trauma and deformity correction, scoliosis treatment, limb lengthening and external fixation, as well as specialized surgical instruments. It also provides related education and support for pediatric orthopedic surgeons and care teams.
Recommended Stories
- Five stocks we like better than OrthoPediatrics
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
